Physicians’ preferences for direct-acting antivirals in the treatment of chronic hepatitis C: evidence from a discrete choice experiment in China
In China's healthcare setting, beyond the central importance of efficacy, physicians also place great emphasis on affordability and economic value, with marked heterogeneity in preferences depending on background characteristics.
Authors
- Juan Du (ORCID: https://orcid.org/0000-0002-2990-5343)
- Chenhui Tian
- Pingyu Chen (ORCID: https://orcid.org/0000-0003-1478-9076)
- Yali Li (ORCID: https://orcid.org/0009-0001-8648-2738)
- Aixia Ma
- Tiantian Tao
Institutions
- China Pharmaceutical University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Expert Review of Pharmacoeconomics & Outcomes Research
- Published
- 2026-03-21
- DOI
- https://doi.org/10.1080/14737167.2026.2650162
- Primary Topic
- Economic and Environmental Valuation
- Type
- article
- Field-Weighted Citation Impact
- 0.00